Identification of antigen-specific IgG in sera from patients with chronic prostatitis (Q33206641)

23 July 2017

title

Identification of antigen-specific IgG in sera from patients with chronic prostatitis (English)

1 reference

23 July 2017

Edward J Dunphy

1

1 reference

23 July 2017

Jens C Eickhoff

2

1 reference

23 July 2017

Charles H Muller

3

1 reference

23 July 2017

Richard E Berger

4

1 reference

23 July 2017

Douglas G McNeel

5

1 reference

23 July 2017

publication date

1 September 2004

1 reference

Journal of Clinical Immunology

23 July 2017

published in

1 reference

23 July 2017

volume

24

1 reference

23 July 2017

issue

5

1 reference

23 July 2017

page(s)

492-502

1 reference

Antibody immunity to prostate cancer associated antigens can be detected in the serum of patients with prostate cancer

23 July 2017

cites work

1 reference

12 December 2020

Autoimmune T cell responses to seminal plasma in chronic pelvic pain syndrome (CPPS)

1 reference

12 December 2020

Immunobiology of human melanoma antigens MART-1 and gp100 and their use for immuno-gene therapy

1 reference

12 December 2020

Recombinant vaccinia-PSA (PROSTVAC) can induce a prostate-specific immune response in androgen-modulated human prostate cancer

1 reference

12 December 2020

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1 reference

12 December 2020

Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer

1 reference

12 December 2020

Serological analysis of human tumor antigens: molecular definition and implications

1 reference

12 December 2020

In vitro and ex vivo expression of nucleolar proteins B23 and p120 in benign and malignant epithelial lesions of the prostate

1 reference

12 December 2020

Tumor vaccines for the management of prostate cancer.

1 reference

12 December 2020

Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.

1 reference

12 December 2020

Dendritic cell-based xenoantigen vaccination for prostate cancer immunotherapy

1 reference

12 December 2020

Naked DNA and adenoviral immunizations for immunotherapy of prostate cancer: a phase I/II clinical trial.

1 reference

12 December 2020

The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

1 reference

12 December 2020

Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection

1 reference

12 December 2020

PSA is a candidate self-antigen in autoimmune chronic prostatitis/chronic pelvic pain syndrome

1 reference

12 December 2020

Immunological alterations in the ejaculate of chronic prostatitis patients: clues for autoimmunity

1 reference

12 December 2020

CHIP is a U-box-dependent E3 ubiquitin ligase: identification of Hsc70 as a target for ubiquitylation

1 reference

12 December 2020

Chronic prostatitis: a thorough search for etiologically involved microorganisms in 1,461 patients

1 reference

12 December 2020

Identification of rat prostatic steroid-binding protein as a target antigen of experimental autoimmune prostatitis: implications for prostate cancer therapy

1 reference

12 December 2020

Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients.

1 reference

12 December 2020

CD4 and CD8 T-lymphocyte recognition of prostate specific antigen in granulomatous prostatitis

1 reference

12 December 2020

Identification of tumor-associated antigens in chronic lymphocytic leukemia by SEREX

1 reference

12 December 2020

Phase II prostate cancer vaccine trial: report of a study involving 37 patients with disease recurrence following primary treatment

1 reference

12 December 2020

The prognostic significance of proliferation-associated nucleolar protein p120 expression in prostate adenocarcinoma: a comparison with cyclins A and B1, Ki-67, proliferating cell nuclear antigen, and p34cdc2.

1 reference

12 December 2020

Autoimmune prostatitis: evidence of T cell reactivity with normal prostatic proteins

1 reference

12 December 2020

Noninflammatory chronic pelvic pain syndrome: immunological study in blood, ejaculate and prostate tissue

1 reference

12 December 2020

Prostate histopathology and the chronic prostatitis/chronic pelvic pain syndrome: a prospective biopsy study

1 reference

12 December 2020

Characterization of human colon cancer antigens recognized by autologous antibodies

1 reference

12 December 2020

Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer.

1 reference

12 December 2020

Exploitation of the antibody repertoire of cancer patients for the identification of human tumor antigens

1 reference

12 December 2020

Naturally occurring prostate cancer antigen-specific T cell responses of a Th1 phenotype can be detected in patients with prostate cancer

1 reference

12 December 2020

cDNA cloning and characterization of a novel nucleolar protein

1 reference

12 December 2020

Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes

1 reference

12 December 2020

Autoantibodies to prostate specific antigen in patients with benign prostatic hyperplasia

1 reference

12 December 2020

Generation of PSA-reactive effector cells after vaccination with a PSA-based vaccine in patients with prostate cancer

1 reference

12 December 2020

Human neoplasms elicit multiple specific immune responses in the autologous host

1 reference

12 December 2020

10.1023/B:JOCI.0000040920.96065.5A

Identifiers

DOI

1 reference

Dimensions Publication ID

23 July 2017

1005370198

0 references

1 reference